PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28679431-5	2017	RESULTS: IgA1 O-glycans bore more sialic acids in patients with RA than in control subjects.	Sialic Acids	34-46	immunoglobulin heavy constant alpha 1	Homo sapiens	9-13	
31913287-4	2020	Moreover, IgA1 and IgA2 have different glycosylation profiles, with IgA1 possessing more sialic acid than IgA2.	Sialic Acids	89-100	immunoglobulin heavy constant alpha 1	Homo sapiens	10-14	
31913287-4	2020	Moreover, IgA1 and IgA2 have different glycosylation profiles, with IgA1 possessing more sialic acid than IgA2.	Sialic Acids	89-100	immunoglobulin heavy constant alpha 1	Homo sapiens	68-72	
31913287-5	2020	Removal of sialic acid increases the pro-inflammatory capacity of IgA1, making it comparable to IgA2.	Sialic Acids	11-22	immunoglobulin heavy constant alpha 1	Homo sapiens	66-70